Literature DB >> 15507868

Transgenic animals in medicine: integration and expression of foreign genes, theoretical and applied aspects.

Igor L Goldman1, Sergei G Kadulin, Sergei V Razin.   

Abstract

The production of different pharmaceutically important human proteins in the mammary gland of transgenic animals constitutes an important field of modern biotechnology. In addition, transgenic animals are used to develop suitable models of various human diseases and the possibility of using transgenic technologies to adapt pigs for xenotransplantation of their organs to humans is widely discussed. All these practical applications depend on the availability of reliable techniques to obtain transgenic animals with the necessary spectrum of transgene(s) expression. In the present review we discuss different aspects of producing transgenic animals by microinjection procedure, including both technical aspects and theoretical issues. As far as the technical aspects are concerned, special emphasis is placed on DNA preparation, microinjection timing, vectors permitting delivery of large genomic fragments, and approaches used to increase integration frequency. The molecular basis of the advantage of transgene microinjection into a male pronucleus is discussed. Finally, different strategies used to obtain polytransgenic animals are critically reviewed. In the section devoted to theoretical issues, the mechanisms of integration and molecular systems regulating transgene expression are extensively discussed. In particular, the importance of the domain-level regulatory systems is outlined and experimental approaches permitting the use of the domain-level regulatory systems of the genes encoding milk proteins are described and discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15507868

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  6 in total

1.  Expression of full-length human pro-urokinase in mammary glands of transgenic mice.

Authors:  Yaroslav Gursky; Robert Bibilashvili; Mikchail Minashkin; Alex Krasnov; Alex Deikin; Tatyana Ermolkevich; Andrey Popov; Lilia Verbovaya; Nicolai Rutkevich; Alexsander Shevelev; Sofia Georgieva; Sergey V Razin; Igor Goldman; Elena Sadchikova
Journal:  Transgenic Res       Date:  2009-04-25       Impact factor: 2.788

2.  Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.

Authors:  Jinhua Li; Xinli Qu; John F Bertram
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

3.  Use of transgenic animals in biotechnology: prospects and problems.

Authors:  O G Maksimenko; A V Deykin; Yu M Khodarovich; P G Georgiev
Journal:  Acta Naturae       Date:  2013-01       Impact factor: 1.845

4.  Variable expression of Cre recombinase transgenes precludes reliable prediction of tissue-specific gene disruption by tail-biopsy genotyping.

Authors:  Tim J Schulz; Markus Glaubitz; Doreen Kuhlow; René Thierbach; Marc Birringer; Pablo Steinberg; Andreas F H Pfeiffer; Michael Ristow
Journal:  PLoS One       Date:  2007-10-10       Impact factor: 3.240

5.  Transgenic pigs designed to express human α-galactosidase to avoid humoral xenograft rejection.

Authors:  J Zeyland; B Gawrońska; W Juzwa; J Jura; A Nowak; R Słomski; Z Smorąg; M Szalata; A Woźniak; D Lipiński
Journal:  J Appl Genet       Date:  2013-06-19       Impact factor: 3.240

6.  HMEJ-mediated efficient site-specific gene integration in chicken cells.

Authors:  Long Xie; Juanjuan Sun; Lifen Mo; Tianpeng Xu; Qaisar Shahzad; Dongyang Chen; Wenhao Yang; Yuying Liao; Yangqing Lu
Journal:  J Biol Eng       Date:  2019-11-21       Impact factor: 4.355

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.